Pub. L. 114-146
Pub. L. 114-146
Pub. L. 114-146 - Adding Zika Virus to the FDA Priority Review Voucher Program Act
114th Congress
Affects: 21 U.S.C. §§ 360n
SECTION 1. SHORT TITLE.
This Act may be cited as the “Adding Zika Virus to the FDA Priority Review Voucher Program Act”.
SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS DISEASE.
Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended—
(1) by redesignating subparagraph (R) as subparagraph (S);
(2) in subparagraph (Q), by striking “Filoviruses” and inserting “Filovirus Diseases”; and
(3) by inserting after subparagraph (Q) the following:
(3)“(R) Zika Virus Disease.”
(3) .
Legislative History
LEGISLATIVE HISTORY—S. 2512:
CONGRESSIONAL RECORD, Vol. 162 (2016):
Mar. 17, considered and passed Senate.
Apr. 12, considered and passed House.
Feedback